Rx Spend On Pipeline Drugs Will Be $43 Bil. Over Next Five Years - HIAA Study
Executive Summary
Pipeline pharmaceuticals will be responsible for 40% of the annual increase in pharmaceutical expenditures over the next five years, according to an insurance industry-sponsored study.
You may also be interested in...
Rx Cost Management Should Emphasize Generics Over Rebates - BC/BS Exec
The goal for pharmacy managers should be a decline in drug budgets over the next few years in light of patent expirations, Regence Blue Shield of Idaho Assistant VP-Pharmacy Services Terrance Killilea told the Pharmaceutical Benefit Management Institute April 28 in Scottsdale, Ariz.
Rx Cost Management Should Emphasize Generics Over Rebates - BC/BS Exec
The goal for pharmacy managers should be a decline in drug budgets over the next few years in light of patent expirations, Regence Blue Shield of Idaho Assistant VP-Pharmacy Services Terrance Killilea told the Pharmaceutical Benefit Management Institute April 28 in Scottsdale, Ariz.
Automated Pharmacy Edits Clear Two-Thirds Of COX-2 Rxs Approved By MVP
Automated point-of-service pharmacy edits were responsible for authorizing 64% of the COX-2 inhibitor scripts approved by the health management organization MVP in the fourth quarter of 1999.